Prostate Cancer Can Be Detected Even in Patients with Decreased PSA Less than 2.5 ng/ml after Treatment of Chronic Prostatitis

Prostate Cancer Can Be Detected Even in Patients with Decreased PSA Less than 2.5 ng/ml after Treatment of Chronic Prostatitis

Bibliographic Details
Main Authors:	Kim, Young Jung, Kim, Sun-Ouck, Ryu, Kwang Ho, Hwang, In Sang, Hwang, Eu Chang, Oh, Kyung Jin, Jung, Seung Il, Kang, Taek Won, Kwon, Dong Deuk, Park, Kwangsung, Ryu, Soo Bang
Format:	Online
Language:	English
Published:	The Korean Urological Association 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151632/

Similar Items

Comparison of Ketoconazole and Estramustine for Treating Patients with Castration-Resistant Prostate Cancer
by: Yun, Bu Hyeon, et al.
Published: (2011)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
by: LIU, Xin, et al.
Published: (2015)

Clinical Significance of Free-to-Total Prostate-Specific Antigen (PSA) Ratio in Advanced Prostate Cancer Patients with PSA Less than 0.1 ng/ml after Hormone Treatment
by: Kim, Dae Il, et al.
Published: (2012)

Predictive Factors for Prostate Cancer in Biopsy of Patients with Prostate-Specific Antigen Levels Equal to or Less Than 4 ng/ml
by: Kim, Hyoung Woo, et al.
Published: (2011)

Nomogram for Prediction of Prostate Cancer with Serum Prostate Specific Antigen Less than 10 ng/mL
by: Ahn, Jae Hyun, et al.
Published: (2014)

Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
by: Lee, Seung Hwan, et al.
Published: (2011)

AB013. The study on the diagnostic value of f/tPSA to the prostate cancer with tPSA greater than 10 ng/mL
by: Li, Yan-Feng, et al.
Published: (2016)

Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10ng/mL?
by: Busato, W. F. S., et al.
Published: (2015)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
by: Hwang, Insang, et al.
Published: (2012)

Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL
by: Lee, Dong Hoon, et al.
Published: (2016)

Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?
by: Kim, Jun Seok, et al.
Published: (2015)

PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5–10.0 ng ml-1 and 10.1–20.0 ng ml-1: a multicenter study
by: Lin, Yu-Rong, et al.
Published: (2015)

The value of percentage free prostate specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria
by: Ezenwa, E.V., et al.
Published: (2012)

Editorial comment to “The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria” and Reply by authors
by: Elabbady, Ahmed, et al.
Published: (2012)

A pilot study on the use of serum glyoxalase as a supplemental biomarker to predict malignant cases of the prostate in the PSA range of 4-20 ng/ml
by: Chavan, Sushant V., et al.
Published: (2011)

Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation
by: Kalaitzis, Christos, et al.
Published: (2014)

Impact of Comorbidity, Race, and Marital Status in Men Referred for Prostate Biopsy with PSA >20 ng/mL: A Pilot Study in High-Risk Patients
by: Klaassen, Zachary, et al.
Published: (2014)

Prostate Cancer with Solitary Metastases to the Bilateral Testis
by: Kim, Sun-Ouck, et al.
Published: (2011)

Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml
by: Ferro, Matteo, et al.
Published: (2013)

Are More Low-Risk Prostate Cancers Detected by Repeated Biopsy? A Retrospective Pilot Study
by: Lee, Seung Je, et al.
Published: (2013)

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml
by: Chen, Rui, et al.
Published: (2015)

Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result
by: Fiamegos, Alexandros, et al.
Published: (2016)

AB189. Prevalence and risk factors of prostate cancer in Chinese men with PSA 4–10 ng/mL underwent TRUS-guided prostate biopsy: the utilization of PAMD score
by: Fang, Dong, et al.
Published: (2016)

Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4–10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score
by: Fang, Dong, et al.
Published: (2015)

Effect of Transurethral Resection of the Prostate on Storage Symptoms in Patients with Benign Prostatic Hyperplasia of Less than 30 ml
by: Kang, Yu Jin, et al.
Published: (2013)

Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?
by: Taverna, Gianluigi, et al.
Published: (2012)

Evaluation of the Prostate Imaging Reporting and Data System for Magnetic Resonance Imaging Diagnosis of Prostate Cancer in Patients with Prostate-specific Antigen <20 ng/ml
by: Wang, Xuan, et al.
Published: (2016)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
by: Hinev, Alexander I., et al.
Published: (2012)

Stromal Tumor of Uncertain Malignant Potential (STUMP) With PSA >500 ng/ml: A Case Report
by: Johnson, Michael H., et al.
Published: (2015)

Penile Growth in Response to Human Chorionic Gonadotropin (hCG) Treatment in Patients with Idiopathic Hypogonadotrophic Hypogonadism
by: Kim, Sun-Ouck, et al.
Published: (2011)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
by: Stephan, Carsten, et al.
Published: (2014)

Prostate-Specific Antigen Density as a Powerful Predictor of Extracapsular Extension and Positive Surgical Margin in Radical Prostatectomy Patients with Prostate-Specific Antigen Levels of Less than 10 ng/ml
by: Chang, Jin-Seok, et al.
Published: (2011)

Single Scrotal Incision Orchiopexy for Children with Palpable Low-Lying Undescended Testis: Early Outcome of a Prospective Randomized Controlled Study
by: Na, Seong Woong, et al.
Published: (2011)

Developing a Follow-Up Strategy for Patients with PSA Ranging from 4 to 10 ng/ml via a New Model to Reduce Unnecessary Prostate Biopsies
by: Zhao, Ruizhe, et al.
Published: (2014)

Evaluation of PCA3 and multiparametric MRI’s: collective benefits before deciding initial prostate biopsy for patients with PSA level between 3-10ng/mL
by: Okcelik, Sezgin, et al.
Published: (2016)

Impact of Real-Time Elastography versus Systematic Prostate Biopsy Method on Cancer Detection Rate in Men with a Serum Prostate-Specific Antigen between 2.5 and 10 ng/mL
by: Taverna, Gianluigi, et al.
Published: (2013)

Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence
by: Truong, M, et al.
Published: (2012)

Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
by: Azab, Sherif, et al.
Published: (2012)

Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
by: Ragavan, N.
Published: (2014)

Prevalence of Antibiotic-Resistant Bacteria on Rectal Swabs and Factors Affecting Resistance to Antibiotics in Patients Undergoing Prostate Biopsy
by: Kim, Jong Beom, et al.
Published: (2014)